Abstract
Cancer survivorship is expected to increase in coming years. Survivors include recipients of hematopoietic stem cell transplantations, signaling the necessity for evidence-based guidelines that focus on long-term follow-up needs. Studies have shown that evidence-based care can improve cancer survivors' quality of life and long-term outcomes. The implication is that early identification and intervention in chronic health problems such as graft-versus-host disease result in improved outcomes and a higher quality of survivorship. These discoveries signal a need to provide specific care management with appropriate and timely screening and preventive services. Recommendations for long-term follow-up post-hematopoietic stem cell transplantation are an important guide to direct clinical practice with this patient population and optimize their outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
